Aaron Kesselheim
Aaron Kesselheim
Professor of Medicine, Harvard Medical School & Brigham and Women's Hospital
Verified email at partners.org - Homepage
Title
Cited by
Cited by
Year
What is pharmacoepidemiology?
BL Strom
Pharmacoepidemiology, 1-26, 2019
11152019
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis
AS Kesselheim, AS Misono, JL Lee, MR Stedman, MA Brookhart, ...
Jama 300 (21), 2514-2526, 2008
5322008
The high cost of prescription drugs in the United States: origins and prospects for reform
AS Kesselheim, J Avorn, A Sarpatwari
Jama 316 (8), 858-871, 2016
3352016
Regulation of medical devices in the United States and European Union
DB Kramer, S Xu, AS Kesselheim
The New England journal of medicine 366 (9), 848-855, 2012
2442012
Contrast-induced nephropathy: how it develops, how to prevent it
MR Rudnick, A Kesselheim, S Goldfarb
Cleveland Clinic journal of medicine 73 (1), 75, 2006
2242006
FDA regulation of mobile health technologies
MB Hamel, NG Cortez, IG Cohen, AS Kesselheim
The New England journal of medicine 371 (4), 372, 2014
2132014
Clinical decision support systems could be modified to reduce ‘alert fatigue’while still minimizing the risk of litigation
AS Kesselheim, K Cresswell, S Phansalkar, DW Bates, A Sheikh
Health affairs 30 (12), 2310-2317, 2011
2092011
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs
AS Kesselheim, MR Stedman, EJ Bubrick, JJ Gagne, AS Misono, JL Lee, ...
Drugs 70 (5), 605-621, 2010
2072010
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer
AS Kesselheim, JA Myers, J Avorn
Jama 305 (22), 2320-2326, 2011
1842011
A randomized study of how physicians interpret research funding disclosures
AS Kesselheim, CT Robertson, JA Myers, SL Rose, V Gillet, KM Ross, ...
New England Journal of Medicine 367 (12), 1119-1127, 2012
1732012
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study
JJ Gagne, NK Choudhry, AS Kesselheim, JM Polinski, D Hutchins, ...
Annals of internal medicine 161 (6), 400-407, 2014
1392014
Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts
JS Yeh, JM Franklin, J Avorn, J Landon, AS Kesselheim
JAMA internal medicine 176 (6), 763-768, 2016
1282016
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review
KE Austad, J Avorn, AS Kesselheim
PLoS medicine 8 (5), 2011
1262011
Pharmaceutical marketing and the new social media
JA Greene, AS Kesselheim
New England Journal of Medicine 363 (22), 2087-2089, 2010
1202010
Electronic medication packaging devices and medication adherence: a systematic review
KD Checchi, KF Huybrechts, J Avorn, AS Kesselheim
Jama 312 (12), 1237-1247, 2014
1122014
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence
AS Kesselheim, AS Misono, WH Shrank, JA Greene, M Doherty, J Avorn, ...
JAMA internal medicine 173 (3), 202-208, 2013
1112013
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
AS Kesselheim, B Wang, JM Franklin, JJ Darrow
BmJ 351, h4633, 2015
1092015
Innovative research methods for studying treatments for rare diseases: methodological review
JJ Gagne, L Thompson, K O’Keefe, AS Kesselheim
Bmj 349, g6802, 2014
1092014
Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints
AS Kesselheim, MM Mello, DM Studdert
PLoS Medicine 8 (4), 2011
1082011
An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences
AS Kesselheim
The Milbank Quarterly 89 (3), 450-502, 2011
1072011
The system can't perform the operation now. Try again later.
Articles 1–20